Other studies implicate RSK2 in transmitting the prosurvival and proliferative signals from oncogenic mutant receptor tyrosine kinase FGFR3 in multiple myeloma, resulting in cell transformation [28,46]. This evidence concerns the gene FGFR3 and plasma cell myeloma.